1. Home
  2. GOSS vs VREX Comparison

GOSS vs VREX Comparison

Compare GOSS & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • VREX
  • Stock Information
  • Founded
  • GOSS 2015
  • VREX 2016
  • Country
  • GOSS United States
  • VREX United States
  • Employees
  • GOSS N/A
  • VREX N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • GOSS Health Care
  • VREX Technology
  • Exchange
  • GOSS Nasdaq
  • VREX Nasdaq
  • Market Cap
  • GOSS 347.8M
  • VREX 443.9M
  • IPO Year
  • GOSS 2019
  • VREX N/A
  • Fundamental
  • Price
  • GOSS $2.47
  • VREX $11.55
  • Analyst Decision
  • GOSS Strong Buy
  • VREX Strong Buy
  • Analyst Count
  • GOSS 4
  • VREX 2
  • Target Price
  • GOSS $8.50
  • VREX $19.50
  • AVG Volume (30 Days)
  • GOSS 3.1M
  • VREX 545.0K
  • Earning Date
  • GOSS 08-05-2025
  • VREX 08-07-2025
  • Dividend Yield
  • GOSS N/A
  • VREX N/A
  • EPS Growth
  • GOSS N/A
  • VREX N/A
  • EPS
  • GOSS N/A
  • VREX N/A
  • Revenue
  • GOSS $40,237,000.00
  • VREX $821,400,000.00
  • Revenue This Year
  • GOSS N/A
  • VREX $5.01
  • Revenue Next Year
  • GOSS $30.65
  • VREX $2.97
  • P/E Ratio
  • GOSS N/A
  • VREX N/A
  • Revenue Growth
  • GOSS N/A
  • VREX N/A
  • 52 Week Low
  • GOSS $0.66
  • VREX $6.76
  • 52 Week High
  • GOSS $2.65
  • VREX $16.93
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 68.08
  • VREX 76.25
  • Support Level
  • GOSS $2.38
  • VREX $11.22
  • Resistance Level
  • GOSS $2.65
  • VREX $11.51
  • Average True Range (ATR)
  • GOSS 0.15
  • VREX 0.49
  • MACD
  • GOSS 0.03
  • VREX 0.05
  • Stochastic Oscillator
  • GOSS 76.67
  • VREX 82.53

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Share on Social Networks: